Concepedia

Dominik Feuerbach

DF

Statistics

Publications

56

Citations

2.2K

H-Index

31

Active since

1993

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Medical University of Lublin

California Northstate University

Midwestern University

Dominik Feuerbach is an author at Novartis (Switzerland) specializing in neuropharmacology, pharmacology, and neuroscience.

Publications per year

1993–2023

56

Publications

56

ADAM17 is the main sheddase for the generation of human triggering receptor expressed in myeloid cells (hTREM2) ectodomain and cleaves TREM2 after Histidine 157

Dominik Feuerbach, Patrick Schindler, Carmen Barske et al. · Neuroscience Letters · 2017 · 186 citations

, , +4

α7 Neuronal Nicotinic Acetylcholine Receptors Are Negatively Regulated by Tyrosine Phosphorylation and Src-Family Kinases

Eric Charpantier, Andreas Wiesner, Kyung-Hye Huh et al. · Journal of Neuroscience · 2005 · 150 citations · Full text

, , +17

The selective nicotinic acetylcholine receptor α7 agonist JN403 is active in animal models of cognition, sensory gating, epilepsy and pain

Dominik Feuerbach, Kurt Lingenhoehl, Hans-Rudolf Olpe et al. · Neuropharmacology · 2008 · 127 citations

, , +14

Distribution and characterisation of somatostatin receptor mRNA and binding sites in the brain and periphery

Dominique Fehlmann, Daniel Langenegger, Edy Schuepbach et al. · Journal of Physiology-Paris · 2000 · 85 citations

, , +10

Sustained Trem2 stabilization accelerates microglia heterogeneity and Aβ pathology in a mouse model of Alzheimer’s disease

Rahul Dhandapani, Marilisa Neri, Mario Bernhard et al. · Cell Reports · 2022 · 79 citations · Full text

, , +17

1–5 of 56